Amgen Inc. Uncategorized Contracts & Agreements
128 Contracts & Agreements
- Agreement between Amgen Inc. and James Bradner, dated December 13, 2023 (Filed With SEC on February 14, 2024)
- Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 14, 2024)
- Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 9, 2023)
- Appendix 3 to the Rule 2.7 Announcement, dated as of December 12, 2022 (Conditions Appendix) (Filed With SEC on December 12, 2022)
- Transaction Agreement, dated as of December 11, 2022, by and among Amgen Inc., Pillartree Limited and Horizon Therapeutics plc (Filed With SEC on December 12, 2022)
- Form of ASR Agreement (Filed With SEC on February 25, 2022)
- Aircraft Time Sharing Agreement, dated December 3, 2021, by and between Amgen Inc. and Robert A. Bradway (Filed With SEC on February 16, 2022)
- Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 16, 2022)
- Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 9, 2021)
- Agreement between Amgen Inc. and Peter Griffith, dated October 18, 2019 (Filed With SEC on May 1, 2020)
- Letter Agreement, dated November 21, 2019, by and between Amgen Inc. and the parties named therein re: Treatment of Certain Product Inventory in connection with Amgens acquisition... (Filed With SEC on February 12, 2020)
- Description of Amgen Inc.s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 12, 2020)
- Letter Agreement, dated June 25, 2019, by and between Amgen Inc. and UCB Celltech (portions of the exhibit have been omitted because they are both (i) not material and (ii) would... (Filed With SEC on July 31, 2019)
- Agreement between Amgen Inc. and Murdo Gordon, dated July 25, 2018 (Filed With SEC on October 31, 2018)
- OFFICERS CERTIFICATE OF AMGEN INC. (Filed With SEC on May 11, 2017)
- Form of Award Notice (Filed With SEC on February 14, 2017)
- Form of Award Notice (Filed With SEC on February 14, 2017)
- Form of Award Notice (Filed With SEC on February 14, 2017)
- OFFICERS CERTIFICATE OF AMGEN INC. (Filed With SEC on August 19, 2016)
- OFFICERS CERTIFICATE OF AMGEN INC. (Filed With SEC on June 14, 2016)
- Form of Award Notice (Filed With SEC on May 2, 2016)
- Form of Award Notice (Filed With SEC on May 2, 2016)
- Form of Award Notice (Filed With SEC on May 2, 2016)
- TERMS AND CONDITIONS (Filed With SEC on March 8, 2016)
- Form of Permanent Global Certificate (Globalurkunde auf Dauer) of CHF 700,000,000 (700,000,000 Swiss francs) Amgen Inc. One AmgenCenter Drive Thousand Oaks, California... (Filed With SEC on March 8, 2016)
- OFFICERS CERTIFICATE OF AMGEN INC. (Filed With SEC on February 25, 2016)
- Form of Award Notice (Filed With SEC on November 2, 2015)
- Form of Award Notice (Filed With SEC on November 2, 2015)
- Form of Award Notice (Filed With SEC on August 5, 2015)
- Form of Award Notice (Filed With SEC on August 5, 2015)
- OFFICERS CERTIFICATE OF AMGEN INC. (Filed With SEC on May 1, 2015)
- Form of Award Notice (Filed With SEC on April 27, 2015)
- Form of Award Notice (Filed With SEC on April 27, 2015)
- Form of Award Notice (Filed With SEC on February 19, 2015)
- Form of Award Notice (Filed With SEC on February 19, 2015)
- OFFICERS CERTIFICATE OF AMGEN INC. (Filed With SEC on May 22, 2014)
- Form of Award Notice (Filed With SEC on April 30, 2014)
- Form of Award Notice (Filed With SEC on April 30, 2014)
- MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED BANK OF AMERICA, N.A. One Bryant Park New York, New York 10036 (Filed With SEC on August 26, 2013)
- Form of Award Notice (Filed With SEC on May 3, 2013)
